The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao

COVID-19 is continuing to ravage globally and has resulted in a huge health and financial burden. Chinese proprietary medicines, such as Lianhua Qingwen (LHQW) and Huoxiang Zhengqi (HXZQ) capsules, have been r...

Source: Chinese Medicine - January 23, 2024 Category: Complementary Medicine Authors: Hui Mo, Man-Fei Zhou, Edmundo Patricio Lopes Lao, Ka-Kei Chan, On-Na Lai, Man-In Ho, Kin-Wa Wong, Ka-Meng Ho, Kin-Tim Sio, Keng-Lam Fong, Yong-Hua Zhao, Seng-Ip Cheang and Iek-Long Lo Tags: Research Source Type: research